News | October 21, 2011

First Male in Texas Treated With SAVI Breast Cancer Therapy

October 21, 2011 — When we think about breast cancer, most of us think of it as a disease only affecting women. The truth is, about 2,140 new cases of invasive breast cancer will be diagnosed among men this year, according to the American Cancer Society.

George Ross was one of those men. Ross is also the first man in Texas to receive the SAVI therapy, an advanced treatment device for breast cancer that provides multiple benefits for patients. The therapy reduces the course of treatment time from six weeks to just five days. Ross was treated at Methodist Dallas Medical Center.

The SAVI applicator can provide important advantages for patients with early-stage breast cancer by delivering a form of radiation therapy known as breast brachytherapy. This approach, which targets the tumor site from inside the breast, is becoming a more widely used alternative to traditional radiation.

Breast brachytherapy typically involves two treatments per day for only five days. This shorter timeframe makes it far more convenient than traditional, external-beam radiation. The latter is delivered five times a week and takes six or seven weeks.

In addition to shortening the therapy time, breast brachytherapy with SAVI minimizes radiation exposure for healthy tissue; this reduces impacts to critical structures such as the skin, heart, lungs and ribs.

"While male breast cancer is much less common than its female counterpart, we are pleased to offer the same leading edge technology for both men and women," says Arve Gillette, M.D., an independently practicing radiation oncologist on the medical staff at Methodist Health System. "We look forward to participating in other advances in treating this disease, whether for women, or the rare but increasingly frequent occurrences among men."

Ross, who discovered the lump that led to his diagnosis of breast cancer, is doing well after the treatment and offers a word of advice to other men. "Check yourself regularly," he says. "You never know."

Methodist Dallas Medical Center was named a Center of Excellence in accelerated partial breast irradiation (APBI) for its use of the SAVI applicator. The designation recognizes a facility's dedication to education, training and experience in APBI.

To qualify, physicians, medical physicists, and clinical staff are required to complete a comprehensive training and education program demonstrating proficiency in delivering radiation therapy with SAVI. Recognized facilities have also expressed a commitment to patient education, advocacy and awareness of advanced breast cancer treatments.

For more information: www.methodisthealthsystem.org

Related Content

China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Electronic Brachytherapy Comparable to Mohs Surgery in Early-Stage Non-Melanoma Skin Cancer Treatment
News | Brachytherapy Systems | July 20, 2017
July 20, 2017 — Rates of recurrence in early-stage non-melanoma skin cancer (NMSC) patients were virtually identical
Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
News | Brachytherapy Systems, Women's Healthcare | May 01, 2017
iCAD Inc. announced the first early-stage breast cancer patient was treated in Australia with intraoperative radiation...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference
News | Brachytherapy Systems | March 15, 2017
CAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative...
prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...
Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer
News | Brachytherapy Systems | January 16, 2017
On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive electronic...
iCAD, IORT boost, Xoft Axxent Electronic Brachytherapy System, intraoperative radiation therapy, whole breast radiation, early-stage breast cancer, SABCS 2016
News | Brachytherapy Systems | January 05, 2017
iCAD Inc. announced that researchers presented updated data on the use of intraoperative radiation therapy (IORT) with...
Samsung, Neurologica, BodyTom CT scanner, Willis-Knighton Health System, Louisiana, La., brachytherapy, radiation therapy, ASTRO 2016
News | Computed Tomography (CT) | October 27, 2016
Samsung announced in September that the Willis-Knighton Cancer Center in Shreveport, La., added BodyTom CT, the world’s...
Overlay Init